期刊文献+

尼莫地平与氟桂利嗪治疗偏头痛的临床观察 被引量:8

A comparative study of nimodipine and flunarizine in treatment of migraine
下载PDF
导出
摘要 目的:观察尼莫地平与氟桂利嗪治疗偏头痛的临床效果。方法:随机将190例偏头痛患者分为两组,观察组96例,给予尼莫地平30 mg/次,每日3次,对照组92例给予氟桂利嗪5 mg/次,每晚1次。结果:尼莫地平与氟桂利嗪治疗偏头痛的临床疗效差异无统计学意义(P>0.05),但不良反应差异有统计学意义(P<0.05)。结论:尼莫地平与氟桂利嗪治疗偏头痛的临床疗效相当,但尼莫地平不良反应较氟桂利嗪少,是目前较为理想的防治偏头痛的药物。 Objective:To explore the clinical efficacy of nimodipine and flunarizine in treatment of migraine.Methods:190 patients with the diagnosis of migraine were randomly divided into experimental group(n=96) and control group(n=92).It was treated for nimodipine(30 mg,three times daily) in experimental group.The control group was treated with flunarizine(5 mg,nightly).Results:There was no significant difference between two groups in efficacy(P0.05).But significant difference was found in side-effect(P0.05).Conclusions:Nimodipine showed the same effect in treatment of migraine with flunarizine and had less side-effects than flunarizine.Nimodipine was thought to be an ideal drug for migraine.
出处 《南通大学学报(医学版)》 2011年第6期448-449,共2页 Journal of Nantong University(Medical sciences)
基金 苏州科技计划项目(SYS201122)
关键词 偏头痛 尼莫地平 氟桂利嗪 不良反应 migraine nimodipine flunarizine side-effects
  • 相关文献

参考文献7

二级参考文献11

共引文献123

同被引文献44

  • 1李颖,冯智英,季伟华,邹静,李焰生.2189例门诊头痛患者的病因分析[J].神经病学与神经康复学杂志,2009,6(1):3-8. 被引量:24
  • 2Sheifcoume CD, Jackson CA, Meredith LS,et al. Prevalence of comorbid anxiety disorders in primary care outpatients[ J]. Arch Fam Med,1996,5( 1);27 -34.
  • 3Hoffert MJ. Treatment of migraine: A new area[J]. American Family Physician, 1994, 15: 633.
  • 4Ebersberger A, Schaible HG, Averbeck B, et al. Is there a correla- tion between spreading depression, neurogenie inflamination, and nociception that might cause migraine headache[J]. Ann Neurol, 2001, 49(1): 713.
  • 5Hargreaves R J, Shepheard SL. Pathophysiology of migraine: New insights[J]. Canadian Journal of Neurological Sciences, 1999, 26 (3): 12-19.
  • 6Wang YH, Liang S, Feng Y, et al. Effect and mechanism of senkyunolide I as an anti-migraine compound from Ligusticum Chuanxiong[J]. J Pharm Pharmacology, 2011, 63(2): 261-266.
  • 7He CY, Wang S, Feng Y, et al. Pharmacokinetics, tissue distribution and metabolism of senkyunolide I, a major bioactive component in Ligusticum chuanxiong Hort. (Umbelliferae) [J]. 2012, 142 (3) : 706- 713.
  • 8洋川芎内酯I在制备防治脑卒中及其康复期相关治疗用药物中的应用[P].中华人民共和国专利,专利申请号:201010107765.7.
  • 9洋川芎内酯H在制备抗抑郁症、偏头痛及其他5-羟色胺能系统相关疾病药物中的应用[P].中华人民共和国专利,专利申请号:200910200688.7.
  • 10Bogdanov VB, Muhon S, Chauve V, et al. Migraine preventive drugs differentially affect cortical spreading depression in rat[J]. Neurobiology of Disease[J]. 2011 (1) : 430-435.

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部